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Abstract 
Background: An abnormally wide spatial QRS-T angle on an ECG is a marker of 
heterogeneity in electrical activity of cardiac ventricles and is linked with cardiovascular 
events. Growing evidence suggests that cardiac dysfunction might signal future cognitive 
decline. 
 
Objective: In this study we investigated whether spatial QRS-T angle associates with future 
cognitive decline in older subjects at high cardiovascular risk. 
 
Methods: We included 4172 men and women (mean age 75.2 ± 3.3 years) free of cardiac 
arrhythmias from the PROSPER cohort. Spatial QRS-T angle was calculated from baseline 12-
lead ECGs using a matrix transformation method. Cognitive function was assessed using 4 
neuropsychological tests including Stroop test, letter-digit coding test, immediate and delayed 
picture word learning tests. Cognitive function was assessed at baseline and repeatedly during 
a mean follow-up time of 3.2 years. Using linear mixed models, we calculated the annual 
changes of cognitive scores in sex-specific thirds of spatial QRS-T angle. 
 
Results: Participants with wider spatial QRS-T angle had a steeper decline in letter-digit 
coding test (β= –0.0106, p=0.004), immediate picture-word learning test (β= –0.0049, p=0.001) 
and delayed picture-word learning test (β= –0.0055, p=0.013). All associations were 
independent of arrhythmias, cardiovascular risk factors, comorbidities, medication use, 
cardiovascular events and other ECG abnormalities including QRS duration, QTc interval, T 
wave abnormalities and left ventricular hypertrophy. 
 
Conclusion: Abnormal cardiac electrical activity characterized by wide spatial QRS-T angle 
associates with accelerated cognitive decline independent of conventional cardiovascular 
factors. These findings suggest a link between a non-traditional ECG measure of pre-clinical 
cardiac pathology and future cognitive decline. 
 
Keywords: Spatial QRS-T angle; Cognitive function; Cardiac dysfunction; Old age 
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Introduction 
The electrical activity of the heart is generated by waves of myocardial depolarization and 
repolarization leading to a harmonized cardiac muscle contraction and relaxation [1]. 
Alterations in the sequence of ventricular depolarization and repolarization are not only 
associated with cardiovascular events [2, 3] but may also precede cerebrovascular events and 
increase risk of stroke [4]. Apart from overt cerebrovascular accidents, ventricular  
repolarization abnormality as measured by QT dispersion has been linked to cognitive 
impairment and Alzheimer’s disease dementia [5]. Hence, early cardiac electrical 
abnormalities might signal future risk of cognitive impairment and such markers may assist in 
identification of high-risk populations. 
 
The spatial QRS-T angle is a non-invasive subclinical marker of electrical activity of cardiac 
ventricles [6]. It quantifies the deviation in the direction of cardiac ventricular depolarization 
and repolarization in a three-dimensional space [7]. A wide spatial QRS-T angle reflects the 
pathophysiological changes in the ionic channels affecting the repolarization profiles, or 
structural abnormalities affecting the sequence of depolarization [8]. A wider spatial QRS-T 
angle has been associated with incident coronary heart disease [2], all-cause and cardiovascular 
mortality [9] and ischemic stroke [10]. Since a wide spatial QRS-T angle is a marker of greater 
inhomogeneity of electrical activity of cardiac ventricles, we aimed to study the independent 
link between spatial QRS-T angle and cognitive decline in older subjects at high risk of 
cardiovascular disease. 
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Methods 
Study design 
The study population consists of the participants from the PROspective Study of Pravastatin in 
the Elderly at Risk (PROSPER). PROSPER was a multicenter randomized clinical trial which 
aimed to assess the effect of pravastatin in prevention of vascular events in older subjects with 
pre-existing cardiovascular risk factors or diseases [11]. In brief, a total of 5804 men and 
women at high cardiovascular risk (defined as being due to smoking, hypertension or diabetes 
mellitus) or with a history of vascular disease (defined as stable angina, intermittent 
claudication, stroke, transient ischemic attack, myocardial infarction [MI] and vascular 
surgery), aged 70 to 82 years, were enrolled from three collaborating centers in Ireland, 
Scotland and the Netherlands. The mean follow-up time was 3.2 years. The original PROSPER 
study was approved by the Medical Ethics Committees of the three collaborating centres and 
complied with the Declaration of Helsinki. All subjects gave written informed consent in 
accordance with the Declaration of Helsinki. 
 
Study participants 
From the baseline electrocardiogram (ECG) recordings, we excluded participants with missing 
spatial QRS-T angle measurements and those with evidence of atrial fibrillation, atrial flutter, 
ectopic atrial rhythms, supraventricular arrhythmias, junctional rhythms, intermittent 
conduction defect and other arrhythmias (n=520). Furthermore, we included only participants 
with at least two cognitive measurements: the baseline and one follow-up measurement. Hence, 
a total of 4172 participants were included for analysis. Compared to the excluded participants, 
the included participants were younger and had a lower prevalence of cardiovascular risk 
factors and co-morbidities (Supplementary Table 1). We included participants from both 
treatment groups since it has been shown that treatment with pravastatin does not affect 
cognitive function [12]. 
 
Spatial QRS-T angle measurement 
Standard 12-lead ECGs were recorded using a Burdick Eclipse 850i electrocardiograph in the 
resting supine position. All the ECGs were recorded in the morning of the first enrolment visit 
(at baseline) before initiation of statin treatment. A fully computerized automated method was 
used to ensure reproducibility of the measurements. The digital ECG recordings were 
transferred to the University of Glasgow ECG Core Lab in Scotland and interpreted using the 
University of Glasgow (Uni-G) ECG analysis program software [13]. The software provided 
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an interpretation of the ECG recordings, Minnesota Codes, and numerous measurements 
including the QRS complex and T waves [13-15]. To calculate the spatial QRS-T angle, we 
first reconstructed the Frank XYZ vectocardiographic leads from the 12-lead ECG recordings 
using the inverse Dower method [16]. We then measured the spatial QRS-T angle as the angle 
between the maximum QRS vector and the maximum T vector. The maximum QRS and T 
vectors were defined as the point of maximum magnitude of the spatial QRS vector and the 
spatial T vector within the 3-dimensional QRS loop and T loop, respectively [6]. Since the cut-
point for spatial QRS-T angle has varied among previous studies [6], we first classified the 
spatial QRS-angle based on the sex-specific tertiles in three groups of low (0°-38° for women 
and 0°-45° for men), middle (39°-75° for women and 46°- 84° for men) and high (76°-180° for 
women and 85°-180° for men). Secondly, based on a cut-point used in previous studies for 
older subjects [9, 17], we classified the spatial QRS-T angle levels in three groups of normal 
(0° to 104°), borderline (105° to 134°), and abnormal (135° to 180°). 
 
The QT interval was calculated from the onset of QRS complex to the T offset and was 
corrected for heart rate (QTc interval) using the Hodges formula [18]. T wave abnormalities 
were defined as Minnesota Codes 5-1, 5-2 and 5-3 [14]. Left ventricular hypertrophy (LVH) 
was defined by using the Sokolow-Lyon voltage criteria [19]. 
 
Cognitive function assessment 
In PROSPER, the mini-mental state examination test (MMSE) was used at baseline for 
screening purposes and participants with poor cognitive function (MMSE score <24) were 
excluded from enrolment in the study [20]. Four cognitive tests were used to assess different 
domains of cognitive function. The cognitive tests included the Stroop test, the letter-digit 
coding test (LDCT), immediate picture-word learning test (PLTi) and delayed picture-word 
learning test (PLTd). A detailed description of the cognitive assessments has been published 
elsewhere [20]. In brief, the Stroop test measures selective attention and reaction time. The 
outcome variable is the total number of seconds to complete the test. In contrast to the other 
cognitive tests used in this study, a higher score in Stroop test indicates worse performance. 
The LDCT measures the processing speed and the outcome variable is the total number of 
correct digits entered in 60 seconds; a higher score indicates better performance. The PLTi and 
PLTd tests measure immediate and delayed memory, respectively. The outcome variables are 
the accumulated number of correctly recalled pictures for the immediate and delayed trials; a 
higher score indicates better performance. Cognitive function was assessed at baseline, after 9, 
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18, 30 months and at the end of the study which varied between 36 and 48 months. During each 
visit, different versions of cognitive tests were used to avoid learning effects [20]. 
 
Statistical analysis 
A p-value<0.05 was considered as statistically significant. Differences in baseline 
characteristics of participants in the three groups of spatial QRS-T angle were compared using 
the ANOVA test for continuous variables and Chi-squared test for categorical variables. Linear 
regression models were used to test the cross-sectional association between spatial QRS-T 
angle and cognitive function at baseline. The dependent variable was the score of each 
cognitive test at baseline. Using analysis of covariance, we calculated the adjusted mean score 
of cognitive tests in sex-specific thirds of spatial QRS-T angle. The Stroop test scores were 
log-transformed because they were not normally distributed. Linear mixed models (random 
regression model with random intercepts and slopes) were used to test the longitudinal 
association between spatial QRS-T angle and changes in cognitive scores over time. The 
models incorporated spatial QRS-T angle, time (in years) and the interaction term between time 
and spatial QRS-T angle. Subjects were defined as random factors and all other variables were 
defined as fixed factors. To assess the mean annual change of cognitive scores in thirds of 
spatial QRS-T angle, we computed the estimates of interaction between time and sex-specific 
thirds of spatial QRS-T angle using linear mixed models. To calculate the estimate of change 
in cognitive scores per 10 degree increase in spatial QRS-T angle, we divided the spatial QRS-
T angle levels by ten. All probability values were calculated using continuous values of spatial 
QRS-T angle. Both cross-sectional and longitudinal analyses were first adjusted for age, sex, 
education (age at which the participant left school), country of enrolment and version of 
cognitive tests where appropriate (model 1). In the next step, adjustment for cardiovascular 
diseases, cardiovascular risk factors and medication use (diuretics, beta-blockers, calcium 
channel blockers, angiotensin converting enzyme inhibitors [ACEI] and angiotensin receptors 
blockers [ARB]) were added (model 2). In longitudinal analysis, further adjustment for statin 
treatment groups was added in model 2. To test the effect of other ECG parameters on the 
longitudinal associations, adjustments for T wave abnormalities, QTc interval, QRS duration 
and LVH were added in model 3. 
 
To test the effect of cardiovascular events on the longitudinal associations, a series of 
sensitivity analyses were performed in which we stratified for the participants according to who 
did and who did not develop incident atrial fibrillation, heart failure hospitalization, coronary 
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events, fatal or non-fatal stroke or transient ischemic attack (TIA) and non-fatal MI during 
follow-up. To test whether the difference between participants who did and who did not 
develop cardiovascular events is significant, p for interactions were calculated using linear 
mixed models. Furthermore, we tested the effect of baseline apolipoprotein e4 phenotype on 
longitudinal associations by stratifying participants in two groups of E4+ carriers (including 
E4/4, E3/4 and E2/4) and E4- carriers. Finally, we tested the effect of baseline cardiovascular co-
morbidities and use of anti-arrhythmic medications on longitudinal associations by excluding 
participants who had history of hypertension, history of diabetes mellitus, history of MI, history 
of stroke or TIA, and participants using anti-arrhythmic medications. 
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Results 
Of the 4172 participants in this study, the mean age was 75.2 ± 3.3 years and 1998 (47.9%) 
participants were male. A total of 2593 (62.2%) had history of hypertension, 427 (10.2%) had 
history of diabetes mellitus, 541 (13.0%) had history of MI and 430 (10.3%) had history of 
stroke or TIA. The mean systolic blood pressure was 154.5 ± 21.8 mmHG, mean diastolic 
blood pressure was 83.7 ± 11.3 mmHG and mean body mass index was 26.9 ± 4.1 kg/m2. 
Subjects with higher spatial QRS-T angle were slightly older, had higher prevalence of 
cardiovascular diseases and risk factors, were more likely to have T-wave abnormalities, had 
higher QTc interval and QRS duration, used ACEI more frequently and used beta-blockers less 
frequently (Table 1). Moreover, participants with higher spatial QRS-T angle were more likely 
to develop incident atrial fibrillation, heart failure hospitalization, coronary events, and non-
fatal MI during follow-up period (Table 1). 
 
Table 2 shows the cross-sectional association between spatial QRS-T and cognitive function at 
baseline. In model 1, higher spatial QRS-T angle was not associated with performance of 
participants in any of the cognitive tests at baseline. Full adjustments for cardiovascular risk 
factors, cardiovascular co-morbidities and medication use did not change the observed 
associations. 
 
Table 3 and Figure 1 show the longitudinal association between spatial QRS-T angle and 
cognitive decline over a period of 3.2 years. In model 1, higher spatial QRS-T angle was 
significantly associated with a steeper decline in the LDCT (β=-0.0106; p-value= 0.004), PLTi 
(β=0-0.0049; p-value= 0.001) and PLTd (β=-0.0055; p-value= 0.013) scores during follow-up. 
After full adjustment for cardiovascular risk factors, cardiovascular co-morbidities and 
medication use, the mean annual change of cognitive scores in thirds of spatial QRS-T angle 
remained essentially the same (Table 3, model 2). Adjustment for baseline level of cognitive 
scores did not essentially change these results (data not shown). Furthermore, we found no 
significant difference in the annual change of cognitive scores between the low and middle 
thirds of spatial QRS-T angle (Supplementary Table 2).   
 
To further explore the effect of other ECG parameters affecting the sequence of ventricular 
repolarization/depolarization on the longitudinal associations, adjustment for T wave 
abnormalities, QTc interval, QRS duration and LVH were added in model 3. Further 
adjustment for these parameters did not essentially change the results, meaning that higher 
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spatial QRS-T angle remained significantly associated with a steeper decline in LDCT, PLTi 
and PLTd test scores (all p-values<0.05) (Table 3, model 3). Furthermore, we tested whether 
an interaction exists between spatial QRS-T angle and these ECG parameters in relation to 
cognitive function and found no significant interaction (all p for interactions > 0.05). The 
estimate (β) and 95% confidence intervals that were assessed using continuous levels of spatial 
QRS-T angle are presented in Supplementary Table 3. When we categorized the spatial QRS-
T angle according to a cut-point that is reported in literature (Normal: 0° to 104°, Borderline: 
105° to 134° and Abnormal: 135° to 180°), the abnormal group was associated with a steeper 
decline in the Stroop, LDCT, PLTi and PLTd tests performances (Supplementary Table 4). 
 
Over a period of 3.2 years, a total of 351 participants developed incident atrial fibrillation, 146 
participants were hospitalized for heart failure, 424 participants developed coronary events, 
279 participants developed stroke or TIA and 335 participants developed non-fatal MI. A total 
of 3235 subjects were free of these cardiovascular events during follow-up. Figure 2 shows the 
longitudinal association of spatial QRS-T angle and cognitive function stratified by incident 
cardiovascular events during follow-up. We did not observe a significant difference in annual 
changes of cognitive function between participants who did and those who did not develop 
incident atrial fibrillation, coronary events, stroke or TIA, heart failure hospitalization and non-
fatal MI during follow-up (all p for interactions > 0.05). Furthermore, there was no interaction 
between baseline apolipoprotein e-4 carriers and spatial QRS-T angle during follow-up 
(Supplementary Table 5). Finally, when we excluded participants with additional 
cardiovascular co-morbidities at baseline and participants taking anti-arrhythmic medications, 
the longitudinal results did not change except that after exclusion of participants with history 
of hypertension (n=1579, >37% of the population) higher spatial QRS-T angle was not 
associated with steeper decline in Stroop and LDCT tests performances (Supplementary Table 
6).  
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Discussion 
Our findings suggest that a wide spatial QRS-T angle, as a reflection of greater heterogeneity 
in electrical activity of cardiac ventricles, associates with accelerated decline in cognitive 
function of older subjects at high cardiovascular risk. These associations were independent of 
arrhythmias, cardiovascular risk factor and co-morbidities, medication use, incident 
cardiovascular events and other ECG parameters. 
 
Previous research has shown that different ECG-parameters measuring either the excitation or 
relaxation phase of the cardiac ventricles are related to cerebrovascular accidents and cognitive 
impairment. For example, men with pathologic Q waves suggesting unrecognized MI have a 
two-fold increased risk of dementia and carry a higher burden of cerebral small vessel disease 
[21]. Similarly, patients with Alzheimer’s disease and mild cognitive impairment have higher 
values of QT dispersion and QT corrected dispersion [5]. Our current study suggests that an 
abnormal spatial QRS-T angle might precede the decline in cognitive function in a large cohort 
of older adults at high cardiovascular risk. Furthermore, the persistence of longitudinal 
associations in subjects without cardiac arrhythmias suggests that even subtle alterations in the 
ventricular electrical activity are linked to cognitive decline. 
 
The observed association between spatial QRS-T angle and cognitive decline can be explained 
through a number of pathophysiological mechanisms. First, a wide spatial QRS-T angle and 
cognitive decline may both reflect cardiovascular damage and hence share a common cause. 
Previous research has shown that spatial QRS-T angle is a strong non-invasive predictor of 
cardiovascular morbidity and mortality [2, 22, 23] and a wide angle is linked with higher 
electric instability of the cardiac ventricles that might increase the risk of cardiac arrhythmias 
and ischemia [7]. The role of cardiovascular risk factors and diseases in development of 
cognitive impairment is well established [24]. In line with this, our results show that subjects 
with higher spatial QRS-T angle have higher prevalence of cardiovascular co-morbidities and 
are more likely to develop incident cardiovascular events during follow-up. Furthermore, 
exclusion of subjects with a history of hypertension at baseline attenuated the longitudinal 
relation of spatial QRS-T angle and executive function as measured by Stroop and LDCT tests. 
However, the relation between spatial QRS-T angle and memory function was independent of 
measured cardiovascular co-morbidities and incident cardiovascular events during follow-up. 
An abnormal spatial QRS-T angle might reflect cardiac changes that results in hemodynamic 
stress and altered brain perfusion, which might in turn lead to global cognitive decline [25]. In 
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line with this, a wide QRS-T angle have been associated with cardiac abnormalities such as 
ventricular remodelling, diastolic dysfunction, impaired ionic channel and calcium 
homeostasis in heart failure patients [26]. Moreover, a wide QRS-T angle has been linked to 
worse left ventricular myocardial performance index in diabetic patients free of cardiovascular 
diseases [27]. Such alterations may cause subtle hemodynamic instability, which may over 
time, lead to cerebral small vessel disease and ultimately to parenchymal damage manifesting 
as cognitive impairment [24, 28]. Nevertheless, we cannot rule out the effect of residual 
confounding and unmeasured cardiovascular factors in our study, which might affect both 
cognitive function and spatial QRS-T angle. Finally, it is also possible that a wide QRS-T angle 
mirrors the already established cerebrovascular damage in the brain which may in turn 
contribute to cognitive impairment [10]. 
 
It is important to mention that the spatial QRS-T angle is superior to other traditional ECG 
parameters measuring cardiac electrical activity since it quantifies the spatial aspects of 
ventricular action potential that are not measured by other ECG-parameters [17]. Furthermore, 
spatial QRS-T angle is a more robust parameter since it is less susceptible to measurement 
errors and noises due to determination of the T wave end on the surface of ECG [7, 29]. Other 
ECG measures of ventricular electrical activity such as QT dispersion and QTc interval are 
highly dependent on the determination of ECG wave points [30]. Moreover, the spatial QRS-
T angle is distinct from other well-known markers of cardiac dysfunction such as troponin and 
B-type natriuretic peptide. Such plasma markers of cardiac dysfunction are released from 
cardiac muscles in response to cardiac wall stretch and/or cardiac muscle damage [31]. 
However, the spatial QRS-T angle is suggested to be increased as a result of subtle cardiac 
ionic channel disturbances and/or cardiac structural abnormalities [7]. As such, spatial QRS-T 
angle might be a non-invasive marker for detection of subtle cardiac abnormalities in an early 
stage [23, 32].  
 
In our analysis, we did not find a cross-sectional association between spatial QRS-T angle and 
cognitive function at baseline. This might be due to the characteristics of participants in the 
original PROSPER cohort in which subjects with poor cognitive function were excluded [11]. 
Since our population consists of older subjects with a fairly preserved cognitive function at 
baseline, the observed association between QRS-T angle and cognitive function might be 
underestimated. Nevertheless, a wide spatial QRS-angle was associated with a significant 
decline in all four cognitive tests during follow-up, strengthening the temporal order of the 
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associations. Furthermore, the threshold for abnormal spatial QRS-T angle varied among 
studies [17, 23, 33] and there is no established cut-off point. When we repeated our analysis 
using a cut-off point from previous literature [9, 17], the results did not essentially change. 
Future research should determine the optimal age and gender specific threshold for abnormal 
spatial QRS-T angle. 
 
The strengths of this study include the large sample size (more than 4000 participants), 
prospective multicentre design and the use of different cognitive tests assessing various 
domains of cognitive function. Furthermore, the non-invasive nature of ECG makes the QRS-
T angle a suitable tool for use in clinical practice and supports its use for cardiovascular 
prevention strategies as well as efforts to prevent cognitive decline. Although measurement of 
spatial QRS-T angle requires a computer program, the implementation of this program using 
modern electrocardiographs is quite easy [17]. One limitation is that the participants had pre-
existing cardiovascular risk factors or disease which might limit generalizability of our findings 
to a healthy older population. Another limitation is that PROSPER had a relatively short 
duration of follow-up which might result in small magnitude of associations and limit the 
clinical significance of our findings. Of note, although the magnitude of associations were 
small, the effect estimates were comparable with the effect estimates of left ventricular 
hypertrophy and apolipoprotein E4 in relation to cognitive decline in the same population [34, 
35]. Moreover, only 10% of the population developed incident events during follow-up which 
might have under-powered our analysis in finding moderating effects of cardiovascular events 
on the reported associations. Finally, this was a secondary analysis of a randomized-controlled 
trial and was not designed to investigate a causal association between ECG abnormalities and 
cognitive decline. 
 
In conclusion, we found that wider spatial QRS-T angle as a reflection of electrical instability 
in cardiac ventricles associates with accelerated cognitive decline independent of several 
conventional cardiovascular risk factors and comorbidities. These findings provide insight into 
the link between pre-clinical cardiac pathologies and development of cognitive decline in 
future. Future work should investigate the prognostic accuracy of a widened QRS-T angle and 
future cognitive decline, with the aim of early intervention into subtle cardiovascular 
abnormality in order to prevent cerebrovascular alterations and cognitive impairment. 
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Table 1. Baseline characteristics of participants in thirds of Spatial QRS-T angle  
 Spatial QRS-T angle thirds  
 
 
Low 
n=1383 
Middle 
n=1393 
High 
n=1396 
 
p-value 
Demographics     
   Age, years, mean (SD) 75.04 (3.29) 75.09 (3.30) 75.33 (3.37) 0.049 
   Age left school, years, mean (SD)  15.22 (2.15) 15.25 (2.11) 15.12 (2.08) 0.253 
   Country, n (%)    0.262 
      Scotland 608 (44.0) 586 (42.1) 624 (44.7)  
      Ireland 489 (35.4) 490 (35.2) 502 (36.0)  
      Netherlands 286 (20.7) 317 (22.8) 270 (19.3)  
Cardiovascular diseases and risk factors 
   History of vascular disease, n (%)  543 (39.3) 568 (40.8) 713 (51.1) <0.001 
   History of stroke or TIA, n (%) 126 (9.1) 140 (10.1) 164 (11.7) 0.068 
   History of MI, n (%) 116 (8.4) 156 (11.2) 269 (19.3) <0.001 
   History of DM, n (%) 123 (8.9) 134 (9.6) 170 (12.2) 0.011 
   History of hypertension, n (%) 841 (60.8) 883 (63.4) 869 (62.2) 0.373 
   LVH, n (%)* 41 (3.0) 112 (8.0) 157 (11.3) <0.001 
   BMI, kg/m2, mean (SD) 26.87 (4.17) 26.69 (3.97) 27.19 (4.25) 0.006 
   SBP, mmHG, mean (SD) 152.17 (21.48) 154.78  )21.51 (  156.58 (22.33) <0.001 
   DBP, mmHG, mean (SD) 83.09 (11.40) 83.67 (10.74) 84.35 (11.61) 0.012 
   Current smoking, n (%) 373 (27.0) 362 (26.0) 351 (25.1) 0.547 
ECG parameters     
   Heart rate, beats/min, mean (SD) 65.70 (11.06) 65.48 (11.47) 66.67 (11.62) 0.014 
   T wave abnormality, n (%)† 184 (13.3) 353 (25.3) 560 (40.1) <0.001 
   QTc interval, sec, mean (SD) 0.424 (0.02) 0.426 (0.03) 0.433 (0.03) <0.001 
   QRS duration, sec, mean (SD) 0.095 (0.02) 0.094 (0.01) 0.105 (0.02) <0.001 
Medications     
   Beta-blocker, n (%) 413 (29.9) 379 (27.2) 325 (23.3) <0.001 
   Diuretic, n (%) 538 (38.9) 561 (40.3) 557 (39.9) 0.747 
   ACE inhibitor, n (%) 188 (13.6) 208 (14.9) 268 (19.2) <0.001 
   ARB, n (%) 26 (1.9) 24 (1.7) 39 (2.8) 0.107 
   Calcium channel blocker, n (%) 324 (23.4) 350 (25.1) 376 (26.9) 0.103 
Incident cardiovascular events during follow-up 
   Atrial fibrillation, n (%) 105 (7.6) 105 (7.5) 141 (10.1) 0.021 
   HF hospitalization, n (%) 34 (2.5) 37 (2.7) 75 (5.4) <0.001 
   Coronary events, n (%) 110 (8.0) 123 (8.8) 191 (13.7) <0.001 
   Non-fatal MI, n (%) 99 (7.2) 99 (7.1) 137 (9.8) 0.011 
   Stroke or TIA, n (%) 89 (6.4) 91 (6.5) 99 (7.1) 0.756 
Cut-points for low, middle and high groups for women are: 0°-38°, 39°-75°, 76°-180°, respectively; 
and for men: 0°-45°, 46°-84°, 85°-180°, respectively. *LVH: LVH based on Sokolow-Lyon index cut 
points (≥3500 µV); †T wave abnormality: Minnesota code 5-1, 5-2 and 5-3. Abbreviations: SD: 
Standard Deviation; n: Number; TIA: Transient Ischemic Attack; MI: Myocardial Infarction; DM: 
Diabetes Mellitus; LVH: Left Ventricular Hypertrophy; BMI: Body Mass Index; SBP: Systolic Blood 
Pressure; DBP: Diastolic Blood Pressure; ACE inhibitors: Angiotensin Converting Enzyme inhibitors; 
ARBs: Angiotensin Receptor Blockers; HF: Heart Failure. 
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Table 2. Cognitive function in relation to spatial QRS-T angle at baseline  
  Spatial QRS-T angle thirds  
 Low 
n=1383 
Middle 
n=1393 
High 
n=1396 
 
p-value* 
Stroop, seconds, mean (SE): 
    Model 1 63.45 (0.61) 62.90 (0.61) 64.64 (0.61) 0.049 
    Model 2 66.04 (1.57) 65.46 (1.57) 66.84 (1.52) 0.166 
LDCT, digits coded, mean (SE): 
    Model 1 24.21 (0.18) 24.06 (0.18) 23.87 (0.18) 0.064 
    Model 2 23.21 (0.45) 23.05 (0.45) 22.99 (0.44) 0.171 
PLTi, pictures remembered, mean (SE): 
    Model 1 9.50 (0.05) 9.55 (0.05) 9.46 (0.05) 0.299 
    Model 2 9.40 (0.12) 9.46 (0.12) 9.39 (0.12) 0.436 
PLTd, pictures remembered, mean (SE): 
    Model 1 10.38 (0.07) 10.47 (0.07) 10.35 (0.07) 0.530 
    Model 2 10.25 (0.17) 10.35 (0.17) 10.28 (0.17) 0.876 
*p-values were calculated using continuous values of spatial QRS-T angle 
Model 1: adjusted for age, sex, country, education and version of cognitive tests where 
applicable; Model 2: adjusted for all the variables in model 1 + history of vascular disease, 
history of diabetes, systolic and diastolic blood pressure, body mass index, smoking status and 
antihypertensive medications. Abbreviations: SE: Standard Error; LDCT: Letter Digit Coding 
Test; PLTi: Picture-Word Learning Test immediate; PLTd: Picture-Word Learning Test 
delayed.  
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Table 3. Cognitive function in relation to spatial QRS-T angle during follow-up  
  Spatial QRS-T angle thirds  
  
 
Low 
n=1383 
Middle 
n=1393 
High 
n=1396 
 
p-value* 
Stroop, seconds, mean annual decline (SE): 
    Model 1 0.488 (0.13) 0.622 (0.13) 0.775 (0.13) 0.055 
    Model 2 0.491 (0.13) 0.625 (0.13) 0.781 (0.13) 0.054 
    Model 3 0.492 (0.13) 0.622 (0.13) 0.781 (0.13) 0.052 
LDCT, digits coded, mean annual decline (SE): 
    Model 1 -0.350 (0.03) -0.345 (0.03) -0.461 (0.03) 0.004 
    Model 2 -0.350 (0.03) -0.346 (0.03) -0.462 (0.03) 0.004 
    Model 3 -0.350 (0.03) -0.346 (0.03) -0.463 (0.03) 0.004 
PLTi, pictures remembered, mean annual decline (SE): 
    Model 1 0.007 (0.01) -0.009 (0.01) -0.034 (0.01) 0.001 
    Model 2 0.007 (0.01) -0.009 (0.01) -0.034 (0.01) 0.001 
    Model 3 0.007 (0.01) -0.010 (0.01) -0.035 (0.01) 0.001 
PLTd, pictures remembered, mean annual decline (SE): 
    Model 1 -0.060 (0.02) -0.054 (0.02) -0.094 (0.02) 0.013 
    Model 2 -0.060 (0.02) -0.054 (0.02) -0.095 (0.02) 0.013 
    Model 3 -0.060 (0.02) -0.054 (0.02) -0.095 (0.02) 0.012 
*p-values were calculated using the interaction term between continuous values of spatial 
QRS-T angle and time. 
Means represent the mean annual decline in the score of each cognitive test. 
Model 1: adjusted for age, sex, country, education and version of cognitive tests where 
applicable; Model 2: adjusted for all the variables in model 1+ history of vascular disease, 
history of diabetes, systolic and diastolic blood pressure, body mass index, smoking status, 
antihypertensive medications and statin treatment groups. Model 3: adjusted for all the 
variables in model 2 + LVH, T wave abnormalities, QTc interval and QRS duration. 
Abbreviations: SE: Standard Error; LDCT: Letter Digit Coding Test; PLTi: Picture-Word 
Learning Test immediate; PLTd: Picture-Word Learning Test delayed. 
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Figure 1. Cognitive function in relation to spatial QRS-T angle during follow-up. Data 
represent mean (standard error) decline in the score of each cognitive test in three groups of 
spatial QRS-T angle. The time point at the end of the study is the mean of end time points (36 
to 48 months). Analyses were adjusted for age, country, education, version of cognitive tests 
where applicable, history of diabetes, history of vascular disease, body mass index, smoking 
status, systolic blood pressure, diastolic blood pressure, antihypertensive medications and 
statin treatment groups. 
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Figure 2. Association of spatial QRS-T angle and annual changes of cognitive function 
stratified for cardiovascular events during follow-up. Data represent annual change (95% 
confidence interval) in cognitive function per each unit (degree) increase in spatial QRS-T 
angle (the X axis), stratified for subjects who did and those who did not develop cardiovascular 
events during follow-up. Dark circles and squares correspond to the annual change (estimate) 
and the lines correspond to the 95% confidence intervals. P-values show the p for interaction. 
Analyses were performed in the fully adjusted model. Abbreviation: MI: myocardial infarction; 
HF: heart failure hospitalization and TIA: transient ischemic attack 
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Supplementary Data 
Supplementary Table 1. Baseline characteristics of included and excluded participants 
 
Characteristics 
Included 
n=4172 
Excluded 
n=1632 
 
p-value 
Socio-demographics:     
   Age, years, mean (SD) 75.2 (3.3) 75.8 (3.4) <0.001 
   Male, n (%) 1998 (47.9) 806 (49.4) 0.305 
   Age left school, years, mean (SD) 15.2 (2.1) 15.0 (1.8) <0.001 
Cardiovascular risk factors: 
   History of vascular disease, n (%) 1824 (43.7) 741 (45.4) 0.245 
   History of stroke or TIA, n (%) 430 (10.0) 219 (13.4) 0.001 
   History of MI, n (%) 541 (13.0) 235 (14.4) 0.097 
   History of DM, n (%) 427 (10.2) 196 (12.0) 0.050 
   SBP, mmHg, mean (SD) 154.5 (21.8) 155.0 (21.8) 0.431 
   DBP, mmHg, mean (SD) 83.7 (11.3) 83.9 (11.9) 0.480 
   BMI, kg/m 2 ,mean (SD) 26.9 (4.1) 26.6 (4.3) 0.015 
   Current smoking, n (%) 1086 (26.0) 472 (28.9) 0.025 
Antihypertensive medications: 
   Beta-blockers, n (%) 1117 (26.8) 385 (23.6) 0.013 
   Diuretics, n (%) 1656 (39.7) 702 (43.0) 0.021 
   ACE inhibitors, n (%) 664 (15.9) 287 (17.6) 0.122 
   ARBs, n (%) 89 (2.1) 27 (1.7) 0.241 
   Calcium channel blockers, n (%) 1050 (25.2) 408 (25.0) 0.895 
Abbreviations: SD: Standard Deviation; n: number; TIA: Transient Ischemic Attack; MI: 
Myocardial Infarction; DM: Diabetes Mellitus; SBP: Systolic Blood Pressure; DBP: Diastolic 
Blood Pressure; BMI: Body Mass Index; ACE inhibitors: Angiotensin Converting Enzyme 
Inhibitors; ARBs: Angiotensin Receptor Blockers. 
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Supplementary Table 2. Comparison of annual changes in cognitive scores between low and 
middle thirds of spatial QRS-T angle 
 Difference of low and middle thirds (95 % CI) p-value 
Stroop, seconds 0.13 (-0.023, 0.49) 0.479 
LDCT, digits coded 0.004 (-0.08, 0.09) 0.924 
PLTi, pictures remembered -0.02 (-0.04, 0.02) 0.229 
PLTd , pictures remembered 0.006 (-0.05, 0.06) 0.832 
Analyses were performed in the fully adjusted model 
Abbreviations: LDCT: Letter Digit Coding Test; PLTi: Picture-Word Learning Test 
immediate; PLTd: Picture-Word Learning Test delayed. 
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Supplementary Table 3. The estimates (β) and 95% confidence intervals for cross-sectional 
and longitudinal analyses 
 Cross-sectional 
Estimate (95% CI) 
Change over time 
Estimate (95% CI) 
Additional annual change 
Estimate (95% CI) 
Stroop test, seconds: 
Model 1* 0.002 (0.00001, 0.004) 0.004 (0.0006, 0.007) 0.0004 (-0.000007, 0.0008) 
Model 2* 0.001 (-0.001, 0.003) 0.004 (0.0007, 0.007) 0.0004 (-0.000006, 0.0008) 
LDCT, digits coded: 
Model 1 -0.042 (-0.086, 0.002) -0.312 (-0.37, -0.25) -0.0106 (-0.018, -0.003) 
Model 2 -0.031 (-0.076, 0.013) -0.312 (-0.37, -0.25) -0.0106 (-0.018, -0.003) 
PLTi, pictures remembered: 
Model 1 -0.006 (-0.018, 0.006) 0.022 (-0.002, 0.047) -0.0049 (-0.008, -0.002) 
Model 2 -0.005 (-0.017, 0.007) 0.022 (-0.002, 0.047) -0.0049 (-0.008, -0.002) 
PLTd, pictures remembered: 
Model 1 -0.005 (-0.022, 0.011) -0.031 (-0.067, 0.005) -0.0055 (-0.098, -0.001) 
Model 2 -0.001 (-0.018, 0.016) -0.031 (-0.067, 0.005) -0.0055 (-0.098, -0.001) 
* estimates and 95% CIs for the natural log-transformed values of Stroop test. 
The term cross-sectional represents the cross-sectional association between spatial QRS-T 
angle and cognitive function at baseline. The term changes over time represents the annual 
changes of cognitive scores during follow-up. The term additional annual change represents 
the extra yearly change in cognitive scores per 10 degree increase in the spatial QRS-T angle 
values. Model 1 is adjusted for age, sex, country, education and version of cognitive tests where 
appropriate; Model 2 is additionally adjusted for history of vascular disease, history of diabetes, 
systolic and diastolic blood pressure, body mass index, smoking status, antihypertensive 
medications and statin treatment groups. Abbreviations: LDCT: Letter Digit Coding Test; 
PLTi: Picture-Word Learning Test immediate; PLTd: Picture-Word Learning Test delayed. 
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Supplementary Table 4. Cognitive function in relation to spatial QRS-T angle during follow-
up, using cut-offs from previous studies 
  Spatial QRS-T angle thirds  
  
 
Normal 
(0°-104°) 
3223 
Borderline 
(105°-134°) 
370 
Abnormal 
(135°-180°) 
579 
 
p-value* 
Stroop, seconds, mean annual decline (SE): 
    Model 1 0.536 (0.08) 0.933 (0.25) 0.954 (0.20) 0.055 
    Model 2 0.540 (0.08) 0.941 (0.25) 0.956 (0.20) 0.054 
LDCT, digits coded, mean annual decline (SE): 
    Model 1 -0.362 (0.02) -0.463 (0.05) -0.467 (0.04) 0.004 
    Model 2 -0.363 (0.02) -0.465 (0.05) -0.467 (0.04) 0.004 
PLTi, pictures remembered, mean annual decline (SE): 
    Model 1 -0.002 (0.008) -0.028 (0.02) -0.059 (0.02) 0.001 
    Model 2 -0.002 (0.008) -0.028 (0.02) -0.059 (0.02) 0.001 
PLTd, pictures remembered, mean annual decline (SE): 
    Model 1 -0.054 (0.01) -0.100 (0.03) -0.132 (0.03) 0.013 
    Model 2 -0.055 (0.01) -0.101 (0.03) -0.133 (0.03) 0.013 
*p-values were calculated using the interaction term between continuous values of spatial 
QRST angle and time. 
Means represent the mean annual decline in the score of each cognitive test. Model 1: adjusted 
for age, sex, country, education and version of cognitive tests where applicable; Model 2: 
adjusted for all the variables in model 1+ history of vascular disease, history of diabetes, 
systolic and diastolic blood pressure, body mass index, smoking status, antihypertensive 
medications and statin treatment groups. Abbreviations: SE: Standard Error; LDCT: Letter 
Digit Coding Test; PLTi: Picture-Word Learning Test immediate; PLTd: Picture-Word 
Learning Test delayed. 
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Supplementary Table 5. Cognitive function in relation to spatial QRS-T angle during follow-
up stratified by APOE e4 at baseline 
  Spatial QRS-T angle   
  Beta (95% CI) P for interaction 
Stroop, seconds* 
    E4+ , n=996 0.00005 (-0.00003, 0.0001) 0.540     E4-, n=3063 0.00003 (-0.00001, 0.00008) 
LDCT, digits coded 
    E4+ , n=996 -0.0009 (-0.002, 0.0005) 0.747     E4-, n=3063 -0.001 (-0.002, -0.0002) 
PLTi, pictures remembered 
    E4+ , n=996 -0.0004 (-0.001, 0.0002) 0.699     E4-, n=3063 -0.0006 (-0.0009, -0.0002) 
PLTd, pictures remembered 
    E4+ , n=996 0.0002 (-0.0007, 0.001) 0.603     E4-, n=3063 -0.0009 (-0.001, -0.0004) 
Estimates and 95% CI for the natural log-transformed values of Stroop test. 
Analyses were performed in the fully adjusted models. E4+ carriers include participants 
with APOE E4/4, E3/4 and E2/4 alleles. 
Abbreviations: LDCT: Letter Digit Coding Test; PLTi: Picture-Word Learning Test 
immediate; PLTd: Picture-Word Learning Test delayed. 
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Supplementary Table 6. Cognitive function in relation to spatial QRS-T angle during follow-
up, after exclusion of participants with cardiovascular co-morbidities at baseline 
  Spatial QRS-T angle thirds  
p-value*   Low Medium High 
Stroop, seconds, mean (SE): 
  No history of hypertension (n=1579) 0.785 (0.20) 0.707 (0.21) 1.008 (0.20) 0.152 
  No history of DM (n=3745) 0.422 (0.13) 0.624 (0.13) 0.725 (0.13) 0.035 
  No history of MI (n=3631) 0.487 (0.14) 0.582 (0.14) 0.836 (0.14) 0.029 
  No history of stroke or TIA(n=3742) 0.415 (0.14) 0.593 (0.14) 0.724 (0.14) 0.045 
  No anti-arrhythmic use (n= 4079) 0.524 (0.13) 0.637 (0.13) 0.737 (0.13) 0.117 
LDCT, digits coded, mean (SE): 
  No history of hypertension (n=1579) -0.431 (0.04) -0.355 (0.04) -0.418 (0.04) 0.943 
  No history of DM (n=3745) -0.326 (0.03) -0.323 (0.03) -0.459 (0.03) 0.002 
  No history of MI (n=3631) -0.359 (0.03) -0.338 (0.03) -0.446 (0.03) 0.029 
  No history of stroke or TIA(n=3742) -0.345 (0.03) -0.347 (0.03) -0.472 (0.03) 0.002 
  No anti-arrhythmic use (n= 4079) -0.355 (0.03) -0.347 (0.03) -0.461 (0.03) 0.009 
PLTi, pictures remembered, mean (SE): 
  No history of hypertension (n=1579) 0.010 (0.02) -0.035 (0.02) -0.037 (0.02) 0.017 
  No history of DM (n=3745) 0.007 (0.01) 0.001 (0.01) -0.028 (0.01) 0.008 
  No history of MI (n=3631) 0.004 (0.01) -0.007 (0.01) -0.037 (0.01) 0.001 
  No history of stroke or TIA(n=3742) 0.007 (0.01) -0.001 (0.01) -0.034 (0.01) 0.002 
  No anti-arrhythmic use (n= 4079) 0.006 (0.01) -0.008 (0.01) -0.034 (0.01) 0.002 
PLTd, pictures remembered, mean (SE): 
  No history of hypertension (n=1579) -0.010 (0.03) -0.111 (0.03) -0.074 (0.03) 0.030 
  No history of DM (n=3745) -0.061 (0.02) -0.042 (0.02) -0.088 (0.02) 0.040 
  No history of MI (n=3631) -0.066 (0.02) -0.058 (0.02) -0.094 (0.02) 0.025 
  No history of stroke or TIA(n=3742) -0.053 (0.02) -0.047 (0.02) -0.096 (0.02) 0.009 
  No anti-arrhythmic use (n= 4079) -0.059 (0.02) -0.052 (0.02) -0.095 (0.02) 0.014 
*p-values were calculated using continuous values of spatial QRS-T angle. 
All analyses were performed in the fully adjusted models (model 2). Abbreviations: SE: 
Standard Error;  PLTi, Picture-Word Learning Test immediate; PLTd, Picture-Word Learning 
Test delayed; LDCT: Letter-Digit Coding Test; DM: Diabetes Mellitus; MI: Myocardial 
Infarction; TIA: Transient Ischemic Attack. 
 
 
 
